Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAROSA3: Pitolisant for Excessive Daytime Sleepiness in Obstructive Sleep Apnea
NCT02739568Phase 3Completed
- Sponsor
- Bioprojet
- Start
- Apr 2016
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of pitolisant in Excessive Daytime Sleepiness (EDS), sponsored by Bioprojet. Started Apr 2016; status: completed.
02
Drugs
pitolisant
03
Conditions
Excessive Daytime Sleepiness (EDS)
Beyond the preview
Go deeper on NCT02739568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02739568.